De novo mutations in schizophrenia implicate synaptic networks.
Fromer, Menachem; Pocklington, Andrew J; Kavanagh, David H; Williams, Hywel J; Dwyer, Sarah; Gormley, Padhraig; Georgieva, Lyudmila; Rees, Elliott; Palta, Priit; Ruderfer, Douglas M; Carrera, Noa; Humphreys, Isla; Johnson, Jessica S; Roussos, Panos; Barker, Douglas D; Banks, Eric; Milanova, Vihra; Grant, Seth G; Hannon, Eilis; Rose, Samuel A; Chambert, Kimberly; Mahajan, Milind; Scolnick, Edward M; Moran, Jennifer L; Kirov, George; Palotie, Aarno; McCarroll, Steven A; Holmans, Peter; Sklar, Pamela; Owen, Michael J; Purcell, Shaun M; O'Donovan, Michael C.
; 506(7487): 179-84, 2014 Feb 13.
Artigo em Inglês | MEDLINE | ID: mdl-24463507
Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis.
Structural connectivity in schizophrenia and its impact on the dynamics of spontaneous functional networks.
Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor function.
Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins.
Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network.
The synapse in schizophrenia.
Mutations of the glycine cleavage system genes possibly affect the negative symptoms of schizophrenia through metabolomic profile changes.
Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions.
Elevated mRNA expression of CASPR3 in patients with schizophrenia.
Randomization and resilience of brain functional networks as systems-level endophenotypes of schizophrenia.